6 үр дүн
TECHNICAL FIELD
The present invention relates to treating malignancies such as tumors or cancers by administering lyophilized compositions comprising arsenic to a subject. Malignancies include various hematological malignancies, such as acute myeloid leukemia (AML) including acute promyelocytic
TECHNICAL FIELD
The present invention relates to treating malignancies such as tumors or cancers by administering lyophilized compositions comprising arsenic to a subject. Malignancies include various hematological malignancies, such as acute myeloid leukemia (AML) including acute promyelocytic
TECHNICAL FIELD
The present invention relates to treating malignancies such as tumors or cancers by administering lyophilized compositions comprising arsenic to a subject. Malignancies include various hematological malignancies, such as acute myeloid leukemia (AML) including acute promyelocytic
FIELD OF THE INVENTION
This invention relates to novel organic arsenic compounds for treating tumor cells and which are particularly effective for inducing apoptosis in leukemia and breast tumor cells.
BACKGROUND OF THE INVENTION
Cancer is a major disease that continues as one of the leading causes
FIELD OF THE INVENTION
This invention relates to novel organic arsenic compounds for treating tumor cells and which are particularly effective for inducing apoptosis in leukemia and breast tumor cells.
BACKGROUND OF THE INVENTION
Cancer is a major disease that continues as one of the leading causes
FIELD OF THE INVENTION
This invention relates to novel organic arsenic compounds for treating tumor cells and which are particularly effective for inducing apoptosis in leukemia and breast tumor cells.
BACKGROUND OF THE INVENTION
Cancer is a major disease that continues as one of the leading causes